Redhill Biopharma
RDHL
#10471
Rank
HK$30.57 M
Marketcap
HK$9.18
Share price
2.61%
Change (1 day)
-81.83%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: HK$30.57 Million

As of December 2025 Redhill Biopharma has a market cap of HK$30.57 Million. This makes Redhill Biopharma the world's 10471th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$30.57 M-55.5%
2024HK$68.69 M-69.38%
2023HK$0.22 B124.39%
2022HK$99.97 M-90.52%
2021HK$1.05 B-55.35%
2020HK$2.36 B41.61%
2019HK$1.66 B35.23%
2018HK$1.23 B44.32%
2017HK$0.85 B-38.26%
2016HK$1.38 B9.04%
2015HK$1.26 B39.65%
2014HK$0.90 B54.2%
2013HK$0.58 B

End of Day market cap according to different sources

On Dec 20th, 2025 the market cap of Redhill Biopharma was reported to be:

HK$30.57 Million
by Nasdaq info icon info icon
HK$30.57 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
HK$915.05 B 2,992,945.72%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$1.964 T 6,426,116.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$771.09 B 2,522,093.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
HK$12.56 B 41,002.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
HK$270.92 B 886,079.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel